Marco Cavaco

13PUBLICATIONS
33CO-AUTHORS
GlycoconjugatesGene and molecular therapyPredictive and prognostic markersMolecular targetsInfectious agents
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 27, 2026
Linker Design in Antibody-Drug Conjugates: Balancing Stability and Drug Release.

|Jun 17, 2026
Chimeric peptide-based radiopharmaceuticals for glioblastoma imaging and therapy by targeting mHsp70 and enhancing BBB penetration.

|Jun 19, 2025
Antimigratory and Antiproliferative Effects of the Brain-Targeted Peptide Conjugate PepH3-vCPP2319 on Triple Negative Breast Cancer Cell Cultures.

Catarina Gonçalves, Miguel A R B Castanho, Marco Cavaco

|Apr 17, 2025
The Potential of Peptide-Based Inhibitors in Disrupting Protein-Protein Interactions for Targeted Cancer Therapy.

Alexandra L Afonso, Catarina T Cavaleiro, Miguel A R B Castanho

|Sep 05, 2023
Quantitative Imaging of the Action of vCPP2319, an Antimicrobial Peptide from a Viral Scaffold, against Staphylococcus aureus Biofilms of a Clinical Isolate.

Susana A Dias, Sandra N Pinto, Ana S Silva-Herdade

|Nov 21, 2022
Selective Inhibition of Bruton's Tyrosine Kinase by a Designed Covalent Ligand Leads to Potent Therapeutic Efficacy in Blood Cancers Relative to Clinically Used Inhibitors.

Bárbara B Sousa, Cátia Rebelo de Almeida, Ana F Barahona

Pageof 3

Frequent Collaborators

12 joint publications

Miguel A R Castanho

9 joint publications

Vera Neves

7 joint publications

David Andreu

3 joint publications

Sira Defaus